| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 22, 2013 | Sale | $12.10 | 1,000 | 12,100 | 166,860 | Jul 23, 2013, 05:10 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 15, 2013 | Sale | $10.55 | 3,500 | 36,925 | 167,860 | Jul 16, 2013, 06:09 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 10, 2013 | Sale | $8.58 | 1,000 | 8,580 | 176,860 | Jul 12, 2013, 06:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 11, 2013 | Sale | $9.32 | 500 | 4,660 | 176,360 | Jul 12, 2013, 06:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 12, 2013 | Sale | $10.10 | 5,000 | 50,500 | 171,360 | Jul 12, 2013, 06:57 PM | |
| TSRX | Trius Therapeutics Inc | MORNEAU MICHAEL | VP Finance & CAO | Jul 11, 2013 | Sale | $6.88 | 40,000 | 275,000 | 32,545 | Jul 12, 2013, 06:56 PM | |
| TSRX | Trius Therapeutics Inc | Bartizal Ken | Chief Development Officer | Jul 01, 2013 | Sale | $8.14 | 2,000 | 16,280 | 95,300 | Jul 01, 2013, 04:44 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Jul 01, 2013 | Sale | $8.14 | 2,000 | 16,280 | 82,022 | Jul 01, 2013, 04:43 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jun 12, 2013 | Sale | $9.08 | 3,000 | 27,250 | 177,860 | Jun 12, 2013, 07:27 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jun 11, 2013 | Sale | $8.94 | 1,000 | 8,940 | 180,860 | Jun 11, 2013, 07:57 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 10, 2013 | Sale | $7.47 | 3,000 | 22,425 | 186,860 | Jun 11, 2013, 07:56 PM | |
| TSRX | Trius Therapeutics Inc | Bartizal Ken | Chief Development Officer | Jun 04, 2013 | Sale | $7.90 | 2,000 | 15,800 | 97,300 | Jun 04, 2013, 07:53 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Jun 03, 2013 | Sale | $7.75 | 2,000 | 15,500 | 84,022 | Jun 03, 2013, 04:49 PM | |
| TSRX | Trius Therapeutics Inc | Bartizal Ken | Chief Development Officer | May 24, 2013 | Sale | $7.93 | 12,000 | 95,119 | 98,927 | May 28, 2013, 07:55 PM | |
| TSRX | Trius Therapeutics Inc | Bartizal Ken | Chief Development Officer | May 14, 2013 | Sale | $7.85 | 12,000 | 94,200 | 110,927 | May 28, 2013, 07:54 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | May 24, 2013 | Sale | $7.93 | 12,000 | 95,119 | 86,022 | May 28, 2013, 07:53 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | May 13, 2013 | Sale | $7.65 | 12,000 | 91,800 | 98,022 | May 28, 2013, 07:42 PM | |
| TSRX | Trius Therapeutics Inc | MORNEAU MICHAEL | VP Finance & CAO | May 14, 2013 | Option Exercise | $5.88 | 40,000 | 235,000 | 30,635 | May 16, 2013, 02:41 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 14, 2013 | Sale | $8.10 | 5,000 | 40,512 | 181,860 | May 16, 2013, 02:28 PM | |
| TSRX | Trius Therapeutics Inc | Bartizal Ken | Chief Development Officer | May 14, 2013 | Sale | $7.85 | 12,000 | 94,200 | 98,927 | May 16, 2013, 02:27 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | May 13, 2013 | Sale | $7.65 | 12,000 | 91,800 | 86,022 | May 15, 2013, 08:35 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 10, 2013 | Sale | $7.47 | 3,000 | 22,425 | 186,860 | May 13, 2013, 01:27 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Apr 24, 2013 | Sale | $7.10 | 500 | 3,550 | 189,860 | Apr 26, 2013, 02:40 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 15, 2013 | Sale | $7.10 | 1,500 | 10,650 | 190,360 | Mar 18, 2013, 02:52 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Jun 22, 2012 | Sale | $6.00 | 1,800 | 10,800 | 107,639 | Jun 25, 2012, 01:07 PM | |
| TSRX | Trius Therapeutics Inc | EASTHAM KARIN | Director | Mar 27, 2012 | Option Exercise | $3.50 | 6,000 | 21,000 | 18,114 | Mar 29, 2012, 11:37 AM | |
| TSRX | Trius Therapeutics Inc | O'Leary Brendan | Director | Mar 26, 2012 | Option Exercise | $2.82 | 21,302 | 60,000 | 21,302 | Mar 28, 2012, 07:50 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Mar 27, 2012 | Option Exercise | $1.29 | 5,000 | 6,450 | 109,439 | Mar 28, 2012, 03:50 PM | |
| TSRX | Trius Therapeutics Inc | Stein Jeffrey | President and CEO | Mar 27, 2012 | Option Exercise | $0.52 | 38,462 | 20,000 | 210,457 | Mar 28, 2012, 03:50 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Mar 26, 2012 | Option Exercise | $1.29 | 9,302 | 12,000 | 9,302 | Mar 27, 2012, 07:50 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 26, 2012 | Option Exercise | $0.52 | 20,000 | 10,400 | 191,860 | Mar 27, 2012, 07:49 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Mar 23, 2012 | Option Exercise | $0.52 | 6,244 | 3,247 | 98,022 | Mar 27, 2012, 05:57 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Jan 13, 2012 | Option Exercise | $0.52 | 4,000 | 2,080 | 91,778 | Mar 27, 2012, 05:56 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Mar 01, 2012 | Sale | $5.04 | 500 | 2,520 | 104,439 | Mar 02, 2012, 02:38 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Feb 02, 2012 | Sale | $5.63 | 500 | 2,815 | 104,939 | Feb 06, 2012, 01:23 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 18, 2012 | Sale | $5.56 | 4,300 | 23,895 | 115,700 | Jan 20, 2012, 09:30 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 19, 2012 | Sale | $5.64 | 2,600 | 14,662 | 113,100 | Jan 20, 2012, 09:30 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Jan 13, 2012 | Option Exercise | $0.52 | 4,000 | 2,080 | 85,070 | Jan 18, 2012, 03:19 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 13, 2012 | Sale | $5.46 | 8,522 | 46,568 | 136,100 | Jan 17, 2012, 06:33 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Jan 17, 2012 | Sale | $5.43 | 16,100 | 87,426 | 120,000 | Jan 17, 2012, 06:33 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Jan 03, 2012 | Sale | $7.28 | 700 | 5,096 | 105,439 | Jan 04, 2012, 04:08 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Dec 01, 2011 | Sale | $7.50 | 700 | 5,250 | 106,139 | Dec 02, 2011, 02:30 PM | |
| TSRX | Trius Therapeutics Inc | Bartizal Ken | Chief Development Officer | Nov 17, 2011 | Sale | $7.85 | 1,687 | 13,243 | 109,844 | Nov 18, 2011, 02:39 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Nov 07, 2011 | Sale | $7.00 | 100 | 700 | 106,839 | Nov 08, 2011, 01:18 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Oct 31, 2011 | Sale | $7.45 | 1,687 | 12,568 | 79,383 | Nov 02, 2011, 07:42 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Oct 27, 2011 | Sale | $7.45 | 1,687 | 12,568 | 81,070 | Nov 02, 2011, 07:25 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Nov 01, 2011 | Sale | $6.75 | 600 | 4,050 | 106,939 | Nov 01, 2011, 04:37 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Oct 27, 2011 | Sale | $7.45 | 1,687 | 12,568 | 79,383 | Oct 31, 2011, 03:18 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Oct 26, 2011 | Sale | $7.00 | 200 | 1,400 | 107,539 | Oct 27, 2011, 01:56 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Oct 11, 2011 | Sale | $6.19 | 500 | 3,095 | 171,860 | Oct 12, 2011, 04:05 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Oct 04, 2011 | Option Exercise | $0.52 | 4,000 | 2,080 | 81,070 | Oct 06, 2011, 01:27 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Oct 03, 2011 | Sale | $6.33 | 600 | 3,798 | 107,739 | Oct 04, 2011, 01:16 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Sep 15, 2011 | Sale | $6.47 | 1,000 | 6,470 | 172,360 | Sep 16, 2011, 02:38 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Sep 01, 2011 | Sale | $6.60 | 600 | 3,960 | 108,339 | Sep 02, 2011, 07:37 PM | |
| TSRX | Trius Therapeutics Inc | TRUEX PAUL F | Director | Aug 29, 2011 | Buy | $6.80 | 2,000 | 13,600 | 13,270 | Aug 31, 2011, 08:02 PM | |
| TSRX | Trius Therapeutics Inc | Prokocimer Philippe | Chief Medical Officer | Aug 22, 2011 | Option Exercise | $0.52 | 4,070 | 2,116 | 77,070 | Aug 24, 2011, 02:39 PM | |
| TSRX | Trius Therapeutics Inc | THOMPSON JOHN CRAIG | Chief Commercial Officer | Aug 22, 2011 | Buy | $6.48 | 133 | 862 | 133 | Aug 24, 2011, 02:39 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Aug 11, 2011 | Sale | $7.00 | 200 | 1,400 | 173,660 | Aug 12, 2011, 06:24 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Aug 12, 2011 | Sale | $7.00 | 300 | 2,100 | 173,360 | Aug 12, 2011, 06:24 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Aug 09, 2011 | Sale | $5.96 | 1,000 | 5,964 | 174,660 | Aug 10, 2011, 12:38 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Aug 01, 2011 | Sale | $8.85 | 1,200 | 10,622 | 109,339 | Aug 02, 2011, 01:16 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Jul 20, 2011 | Sale | $8.00 | 100 | 800 | 110,139 | Jul 21, 2011, 04:45 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 20, 2011 | Sale | $8.00 | 500 | 4,000 | 174,860 | Jul 21, 2011, 04:44 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jul 12, 2011 | Sale | $7.23 | 1,500 | 10,846 | 175,360 | Jul 13, 2011, 03:03 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Jul 01, 2011 | Sale | $7.93 | 700 | 5,550 | 110,239 | Jul 05, 2011, 02:37 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Jun 09, 2011 | Sale | $8.09 | 2,000 | 16,188 | 176,860 | Jun 10, 2011, 04:13 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Jun 01, 2011 | Sale | $7.90 | 800 | 6,323 | 111,039 | Jun 01, 2011, 09:13 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | May 16, 2011 | Sale | $8.00 | 400 | 3,200 | 111,739 | May 18, 2011, 01:05 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 16, 2011 | Sale | $8.02 | 7,000 | 56,163 | 178,860 | May 17, 2011, 01:45 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 12, 2011 | Sale | $7.00 | 1,500 | 10,500 | 185,860 | May 13, 2011, 01:22 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 10, 2011 | Sale | $6.02 | 1,000 | 6,018 | 187,360 | May 10, 2011, 07:04 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | May 05, 2011 | Sale | $7.00 | 200 | 1,400 | 112,139 | May 09, 2011, 01:51 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | May 03, 2011 | Sale | $6.00 | 800 | 4,800 | 188,360 | May 04, 2011, 01:28 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | May 03, 2011 | Sale | $6.00 | 200 | 1,200 | 112,339 | May 03, 2011, 04:07 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | May 02, 2011 | Sale | $5.62 | 500 | 2,810 | 112,539 | May 03, 2011, 04:07 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Apr 11, 2011 | Sale | $5.36 | 500 | 2,678 | 189,160 | Apr 12, 2011, 03:41 PM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Apr 01, 2011 | Sale | $5.66 | 500 | 2,830 | 113,039 | Apr 04, 2011, 02:07 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 30, 2011 | Sale | $6.00 | 200 | 1,200 | 189,660 | Mar 31, 2011, 08:17 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 09, 2011 | Sale | $5.86 | 500 | 2,930 | 189,860 | Mar 10, 2011, 05:19 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Mar 01, 2011 | Sale | $7.00 | 500 | 3,500 | 190,360 | Mar 03, 2011, 06:50 AM | |
| TSRX | Trius Therapeutics Inc | Schmid John P. | CFO and Secretary | Mar 01, 2011 | Sale | $7.04 | 1,400 | 9,856 | 113,539 | Mar 03, 2011, 06:49 AM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Feb 17, 2011 | Sale | $5.00 | 500 | 2,500 | 191,360 | Feb 22, 2011, 03:00 PM | |
| TSRX | Trius Therapeutics Inc | Finn John | Chief Scientific Officer | Feb 18, 2011 | Sale | $6.00 | 500 | 3,000 | 190,860 | Feb 22, 2011, 03:00 PM | |
| TSRX | Trius Therapeutics Inc | Stein Jeffrey | President and CEO | Dec 15, 2010 | Option Exercise | $0.52 | 22,700 | 11,804 | 171,995 | Dec 16, 2010, 02:05 PM | |
| TSRX | Trius Therapeutics Inc | TRUEX PAUL F | Director | Nov 23, 2010 | Option Exercise | $1.55 | 8,364 | 13,000 | 11,270 | Nov 24, 2010, 12:36 PM | |
| TSRX | Trius Therapeutics Inc | KABAKOFF DAVID S | Director | Oct 08, 2010 | Option Exercise | $1.29 | 18,531 | 23,905 | 53,101 | Oct 12, 2010, 12:58 PM | |
| TSRX | Trius Therapeutics Inc | KABAKOFF DAVID S | Director | Oct 08, 2010 | Option Exercise | $1.29 | 11,120 | 14,345 | 52,980 | Oct 12, 2010, 12:58 PM | |
| TSRX | Trius Therapeutics Inc | HEALY JAMES | 10% Owner | Aug 06, 2010 | Buy | $4.68 | 1,723,395 | 8,063,070 | 3,615,572 | Aug 18, 2010, 01:40 PM | |
| TSRX | Trius Therapeutics Inc | Prism Venture Partners V L P | 10% Owner | Aug 06, 2010 | Buy | $4.80 | 1,759,852 | 8,448,454 | 2,958,230 | Aug 10, 2010, 03:40 PM | |
| TSRX | Trius Therapeutics Inc | ATWOOD BRIAN G | Director | Aug 06, 2010 | Option Exercise | $4.72 | 1,659,025 | 7,833,538 | 3,235,839 | Aug 10, 2010, 03:11 PM | |
| TSRX | Trius Therapeutics Inc | SOFINNOVA VENTURE PARTNERS VII L P | 10% Owner | Aug 06, 2010 | Option Exercise | $4.68 | 1,723,395 | 8,063,070 | 3,615,572 | Aug 10, 2010, 02:14 PM | |
| TSRX | Trius Therapeutics Inc | Versant Side Fund III, L.P. | 10% Owner | Aug 06, 2010 | Option Exercise | $4.72 | 1,659,025 | 7,833,538 | 3,235,839 | Aug 10, 2010, 02:12 PM | |
| TSRX | Trius Therapeutics Inc | EASTHAM KARIN | Director | Aug 06, 2010 | Option Exercise | $4.38 | 12,114 | 53,059 | 12,114 | Aug 10, 2010, 02:09 PM | |
| TSRX | Trius Therapeutics Inc | KABAKOFF DAVID S | Director | Aug 06, 2010 | Buy | $5.00 | 30,000 | 150,000 | 34,570 | Aug 10, 2010, 02:07 PM | |
| TSRX | Trius Therapeutics Inc | POWELL MICHAEL | Director | Aug 06, 2010 | Buy | $4.68 | 1,723,395 | 8,063,070 | 3,615,572 | Aug 10, 2010, 01:55 PM | |
| TSRX | Trius Therapeutics Inc | SWEENEY MICHAEL B | Managing Director | Aug 06, 2010 | Option Exercise | $4.77 | 1,971,829 | 9,397,558 | 3,548,643 | Aug 10, 2010, 01:54 PM | |
| TSRX | Trius Therapeutics Inc | NASR KHALED | Venture Members | Aug 06, 2010 | Option Exercise | $4.77 | 1,971,829 | 9,397,558 | 3,548,643 | Aug 10, 2010, 01:52 PM | |
| TSRX | Trius Therapeutics Inc | Kjellson Nina S | Director | Aug 06, 2010 | Buy | $4.77 | 1,971,829 | 9,397,558 | 3,548,643 | Aug 10, 2010, 01:50 PM | |
| TRSX | Trius Therapeutics Inc | KPCB PBD Founders Fund, LLC | 10% Owner | Aug 06, 2010 | Buy | $5.00 | 4,901 | 24,505 | 14,145 | Aug 10, 2010, 06:04 AM | |
| TRSX | Trius Therapeutics Inc | KPCB PBD Associates, LLC | 10% Owner | Aug 06, 2010 | Buy | $5.00 | 823,906 | 4,119,530 | 2,387,125 | Aug 10, 2010, 06:03 AM |
Menu